PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23348585-0	2013	Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms.	farnesylthiosalicylic acid	0-9	TNF superfamily member 10	Homo sapiens	46-51	
23348585-3	2013	In this work, we evaluate whether salirasib sensitizes those cells to TRAIL-induced apoptosis.	farnesylthiosalicylic acid	34-43	TNF superfamily member 10	Homo sapiens	70-75	
23348585-5	2013	Our results show that pretreatment with salirasib sensitized human hepatocarcinoma cell lines, but not normal human hepatocytes, to TRAIL-induced apoptosis.	farnesylthiosalicylic acid	40-49	TNF superfamily member 10	Homo sapiens	132-137	
23348585-9	2013	Furthermore, TRAIL-induced apoptosis in HCC cells pretreated with salirasib was dependent on activation of death receptor (DR) 5.	farnesylthiosalicylic acid	66-75	TNF superfamily member 10	Homo sapiens	13-18	
23348585-10	2013	In conclusion, salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis by a mechanism involving the DR5 receptor and survivin inhibition.	farnesylthiosalicylic acid	15-24	TNF superfamily member 10	Homo sapiens	61-66